Skip to main content
Top
Gepubliceerd in: Tijdschrift voor Urologie 5/2014

01-08-2014

Case reports. Niercelcarcinoom met tumortrombus in vena cava en rechter atrium

Auteurs: drs. J.G.H. Poerink, dr. G.S.C. Geuzebroek, drs. K.W.H. Gisolf, drs. T.L. de Kroon, drs. R.H.W. van de Mortel, dr. J. Wille

Gepubliceerd in: Tijdschrift voor Urologie | Uitgave 5/2014

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Samenvatting

Niercelcarcinoom is de meest voorkomende maligniteit van de nier. In 4-10% van de gevallen is er sprake van trombusingroei via de vena renalis in de vena cava inferior, in 1% tot in het rechter atrium. Symptomen kunnen hematurie of flankpijn zijn, maar zijn vaak atypisch of helemaal afwezig. In deze klinische les illustreren wij de verschillende presentaties van patiënten met niercelcarcinoom en tumortrombus in de vena cava. We benadrukken de noodzaak tot zorgvuldige preoperatieve planning, waarbij de uroloog, vaatchirurg en cardiothoracaal chirurg in nauw teamverband samen dienen te werken.
Literatuur
2.
go back to reference Mellemgaard A, Engholm G, McLaughlin JK, Olsen JH. Risk factors for renal cell carcinoma in Denmark. I. Role of socioeconomic status, tobacco use, beverages, and family history. Cancer Causes Control. 1994 Mar;5(2):105-13.PubMedCrossRef Mellemgaard A, Engholm G, McLaughlin JK, Olsen JH. Risk factors for renal cell carcinoma in Denmark. I. Role of socioeconomic status, tobacco use, beverages, and family history. Cancer Causes Control. 1994 Mar;5(2):105-13.PubMedCrossRef
3.
go back to reference Cotran RS, Kumar V, Collins T. Robbins pathologic basis of disease. 6th ed. Philadelphia: W.B. Saunders Company. 1999. Cotran RS, Kumar V, Collins T. Robbins pathologic basis of disease. 6th ed. Philadelphia: W.B. Saunders Company. 1999.
4.
go back to reference Wotkowicz C, Wszolek MF, Libertino JA. Resection of renal tumors invading the vena cava. Urol Clin N Am. 2008;35:657-71.CrossRef Wotkowicz C, Wszolek MF, Libertino JA. Resection of renal tumors invading the vena cava. Urol Clin N Am. 2008;35:657-71.CrossRef
5.
go back to reference Motzer RJ, Mazumdar M, Bacik J, Berg W, et al. Survival and prognostic stratification of 670 patients with advanced renal cell carcinoma. J Clin Oncol. 1999 Aug;17(8):2530-40.PubMed Motzer RJ, Mazumdar M, Bacik J, Berg W, et al. Survival and prognostic stratification of 670 patients with advanced renal cell carcinoma. J Clin Oncol. 1999 Aug;17(8):2530-40.PubMed
6.
go back to reference Nesbitt JC, Soltero ER, Dinney CPN, et al. Surgical management of renal cell carcinoma with inferior vena cava tumor thrombus. Ann Thorac Surg. 1997;63:1592-600.PubMedCrossRef Nesbitt JC, Soltero ER, Dinney CPN, et al. Surgical management of renal cell carcinoma with inferior vena cava tumor thrombus. Ann Thorac Surg. 1997;63:1592-600.PubMedCrossRef
7.
go back to reference Miyake H, Terakawa T, Furukawa J, et al. Prognostic significance of tumor extension into venous system in patients undergoing surgical treatment for renal cell carcinoma with venous tumor thrombus. EJSO. 2012;38(7):630-6.PubMedCrossRef Miyake H, Terakawa T, Furukawa J, et al. Prognostic significance of tumor extension into venous system in patients undergoing surgical treatment for renal cell carcinoma with venous tumor thrombus. EJSO. 2012;38(7):630-6.PubMedCrossRef
8.
go back to reference Flanigan RC, Salmon SE, Blumenstein BA, et al. Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer. N Engl J Med. 2001;345(23):1655-9.CrossRef Flanigan RC, Salmon SE, Blumenstein BA, et al. Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer. N Engl J Med. 2001;345(23):1655-9.CrossRef
9.
go back to reference Coppin C, Kollmannsberger C, Le L, et al. Targeted therapy for advanced renal cell cancer (RCC): a Cochrane systematic review of published randomised trials. BJU Int. 2011 Nov;108(10):1556-63.PubMedCrossRef Coppin C, Kollmannsberger C, Le L, et al. Targeted therapy for advanced renal cell cancer (RCC): a Cochrane systematic review of published randomised trials. BJU Int. 2011 Nov;108(10):1556-63.PubMedCrossRef
10.
go back to reference Bex A, Blank C, Meinhardt W, et al. A phase II study of presurgical sunitinib in patients with metastatic clear-cell renal carcinoma and the primary tumor in situ. Urology. 2011 Oct;78(4):832-7.PubMedCrossRef Bex A, Blank C, Meinhardt W, et al. A phase II study of presurgical sunitinib in patients with metastatic clear-cell renal carcinoma and the primary tumor in situ. Urology. 2011 Oct;78(4):832-7.PubMedCrossRef
Metagegevens
Titel
Case reports. Niercelcarcinoom met tumortrombus in vena cava en rechter atrium
Auteurs
drs. J.G.H. Poerink
dr. G.S.C. Geuzebroek
drs. K.W.H. Gisolf
drs. T.L. de Kroon
drs. R.H.W. van de Mortel
dr. J. Wille
Publicatiedatum
01-08-2014
Uitgeverij
Bohn Stafleu van Loghum
Gepubliceerd in
Tijdschrift voor Urologie / Uitgave 5/2014
Print ISSN: 2211-3037
Elektronisch ISSN: 2211-4718
DOI
https://doi.org/10.1007/s13629-014-0066-8

Andere artikelen Uitgave 5/2014

Tijdschrift voor Urologie 5/2014 Naar de uitgave

EditorialNotes

Editorial